TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Profound Medical ( (TSE:PRN) ) has issued an announcement.
Profound Medical announced the launch of its TULSA-AI Volume Reduction module, designed to optimize the treatment of benign prostatic hyperplasia (BPH), at the RSNA meeting. This new module enhances the TULSA Procedure’s efficiency, allowing multiple prostate cases to be handled in one day, potentially tripling the company’s market reach to 600,000 patients annually. The TULSA Procedure’s benefits, such as reduced risk of sexual dysfunction and quicker recovery times, are expected to drive its adoption among patients and healthcare providers.
The most recent analyst rating on (TSE:PRN) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on Profound Medical stock, see the TSE:PRN Stock Forecast page.
Spark’s Take on TSE:PRN Stock
According to Spark, TipRanks’ AI Analyst, TSE:PRN is a Neutral.
Profound Medical’s stock score reflects the company’s strong revenue growth and strategic potential, balanced by operational inefficiencies and financial challenges. Technical indicators suggest caution due to bearish trends, while valuation remains a concern with negative earnings. Positive earnings call sentiment and future growth prospects are encouraging, yet immediate operational improvements are necessary for sustained success.
To see Spark’s full report on TSE:PRN stock, click here.
More about Profound Medical
Profound Medical Corp. is a commercial-stage medical device company that specializes in developing and marketing AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company focuses on providing innovative solutions for prostate disease, including prostate cancer and benign prostatic hyperplasia (BPH).
Average Trading Volume: 20,956
Technical Sentiment Signal: Hold
Current Market Cap: C$271.7M
Find detailed analytics on PRN stock on TipRanks’ Stock Analysis page.